Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin Bolus vs Continuous Infusion in Type 1 HRS
NCT00742690Phase 3Unknown
- Sponsor
- Università di Padova
- Start
- May 2005
- Primary completion
- Dec 2014
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of terlipressin in hepatorenal syndrome type 1 (HRS-1), sponsored by Università di Padova. Status: unknown.
02
Drugs
terlipressin
03
Conditions
hepatorenal syndrome type 1 (HRS-1)
Beyond the preview
Go deeper on NCT00742690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742690.